Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Benigno C. Valdez
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
5-Aza-2′-Deoxycytidine Sensitizes Busulfan-Resistant Myeloid Leukemia Cells by Regulating Expression of Genes Involved in Cell Cycle Checkpoint and Apoptosis
Leukemia Research
Cancer Research
Oncology
Hematology
Related publications
Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Mitoxantrone-Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Relapsed/Refractory Lymphoma
Turkish Journal of Medical Sciences
Medicine
Phase I Dose-Escalation Study of Venetoclax Plus Beam Followed by Autologous Stem Cell Transplant (Asct) for Chemoresistant, Relapsed/Refractory, or High-Risk Non-Hodgkin's Lymphoma (Nhl); Preliminary Results
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation for Hodgkin's Disease: Busulfan, Melphalan and Thiotepa Compared to a Radiation-Based Regimen
Bone Marrow Transplantation
Transplantation
Hematology
LACE-conditioned Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin's Lymphoma: Treatment Outcome and Risk Factor Analysis in 67 Patients From a Single Centre
Bone Marrow Transplantation
Transplantation
Hematology
Infections Following Autologous Stem Cell Transplantation for Hodgkin'S Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin's Lymphoma: An Open-Label Phase 1 Trial
The Lancet
Medicine
High Dose Melphalan, BCNU and Etoposide With Autologous Bone Marrow Transplantation for Hodgkin's Disease
British Journal of Cancer
Cancer Research
Oncology
Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
